For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the emergence of this treatment and Attruby represents a significant change. These novel therapies preserve https://attruby867399.blog4youth.com/42655481/major-attr-cm-development-tafamidis-and-attruby-offer-hope